Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease

Heart

Volumn 101, Issue 14, 2015, Pages 1103-1110

  Rothnie, Kieran J ^a   Smeeth, Liam ^a,b   Herrett, Emily ^a   Pearce, Neil ^a   Hemingway, Harry ^b,c   Wedzicha, Jadwiga ^d   Timmis, Adam ^b,e   Quint, Jennifer K ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Farr Institute of Health Informatics Research   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE; CARDIOVASCULAR AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DELAYED DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME TO TREATMENT; UNITED KINGDOM; CLINICAL AUDIT; COMORBIDITY; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; EPIDEMIOLOGY; HEALTH CARE DISPARITY; HEART MUSCLE REPERFUSION; HOSPITAL MORTALITY; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; COMORBIDITY; CORONARY ANGIOGRAPHY; DELAYED DIAGNOSIS; FEMALE; HEALTHCARE DISPARITIES; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MEDICAL AUDIT; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84934275549     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-307251     Document Type: Article

References (22)

1. Schneider C, Bothner U, Jick SS, et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol 2010;25:253-60.
2. Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010;65:956-62.
3. Enriquez JR, de Lemos JA, Parikh SV, et al. Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction. Am Heart J 2013;165:43-9.
4. Dziewierz A, Siudak Z, Rakowski T, et al. Relationship between chronic obstructive pulmonary disease and in-hospital management and outcomes in patients with acute myocardial infarction. Kardiol Pol 2010;68:294-301.
5. Andell P, Koul S, Martinsson A, et al. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Heart 2014;1:e000002.
6. Stefan MS, Bannuru RR, Lessard D, et al. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest 2012;141:1441-8.
7. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
8. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: Role of comorbidities. Eur Respir J 2006;28:1245-57.
9. Setoguchi S, Glynn RJ, Avorn J, et al. Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge A 10-Year Trend Analysis. J Am Coll Cardiol 2008;51:1247-54.
10. Stefan M, Bannuru R, Lessard D, et al. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction; a ten-year retrospective observational study. J Hosp Med 2012;7:S64-S5.
11. Quint JK, Herrett E, Bhaskaran K, et al. Effect of beta blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records. BMJ 2013;347:f6650.
12. Herrett E, Smeeth L, Walker L, et al. The Myocardial Ischaemia National Audit Project (MINAP). Heart 2010;96:1264-7.
13. CPRD. Available from: www.cprd.com.
14. Denaxas SC, George J, Herrett E, et al. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 2012;41:1625-38.
15. Cattle BA, Baxter PD, Greenwood DC, et al. Multiple imputation for completion of a national clinical audit dataset. Stat Med 2011;30:2736-53.
16. Bursi F, Vassallo R, Weston SA, et al. Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J 2010;160:95-101.
17. Rha SW, Li YJ, Chen KY, et al. Impact of chronic obstructive pulmonary disease on the clinical characteristics and outcomes in propensity-matched patients with acute myocardial infarction. Am J Cardiol 2009;103(9):36B-7B.
18. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol 2007;99:636-41.
19. NICE. Unstable angina and NSTEMI (2013 update). 2010.
20. McAllister DA, Maclay JD, Mills NL, et al. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur Respir J 2012;39:1097-103.
21. Neukamm AMC, Hoiseth AD, Hagve TA, et al. High-sensitivity cardiac troponin T levels are increased in stable COPD. Heart 2013;99:382-7.
22. Hadi HA, Zubaid M, Al Mahmeed W, et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome in the current era. Circulation 2010;122:E48.